tiprankstipranks
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market

Phathom Pharmaceuticals (PHAT) Stock Investors

247 Followers
Based on 747,525 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold PHAT
On average, investors allocate 0.00% of their portfolios to PHAT
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 747,525 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding PHAT

1.6%
Last 7
Days
12.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding PHAT, out of 747,525 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

PHAT Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
4.76%
$9.48
Based on the activity of 14,195 investors who made their portfolios public
The table shows changes in PHAT in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

PHAT Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.81%
-1.48%
-2.00%
32.41B
Consumer Cyclical
ChargePoint Holdings
4.17%
-1.00%
-2.43%
833.60M
Consumer Cyclical
Raytheon Technologies
4.04%
-1.17%
-1.61%
136.69B
Industrials
Marathon Digital Holdings
5.78%
-0.18%
+0.20%
6.75B
Financial
NextEra Energy
4.00%
-0.85%
-0.74%
147.93B
Utilities
Riot Platforms
5.15%
-0.53%
+0.54%
3.47B
Financial
Applied Materials
4.53%
+0.37%
+5.15%
174.09B
Technology
Plug Power
5.02%
-1.49%
-3.21%
1.87B
Industrials
Merck & Company
3.90%
-0.58%
+3.35%
318.55B
Healthcare
Microstrategy
7.07%
+1.56%
+7.77%
31.55B
Technology
Based on the activity of 747,525 active portfolios
Open your Smart Portfolio

PHAT Investor Analysis

PHAT investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
5.9%
of PHAT holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
PHAT investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
61.8%
of PHAT holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
PHAT investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
32.4%
of PHAT holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of PHAT stock investors
See who invests in PHAT according to age group and performance.

FAQ

How many retail Investors hold PHAT?
<0.1% of TipRanks' retail investors hold PHAT in their portfolios.
    What is PHAT Investor Sentiment?
    PHAT’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of PHAT in the last 7 days?
      ▲ 1.6% of TipRanks' retail investors changed their holding of PHAT in the last 7 days.
        What percentage of retail investors changed their holding of PHAT in the last 30 days?
        ▲ 12.5% of TipRanks' retail investors changed their holding of PHAT in the last 30 days.
          What is the average age of retail investors who hold PHAT?
          The average age of PHAT Holders is between 35–55.
            What other stocks have PHAT investors also bought?
            PHAT Investors also bought DKNG, CHPT, RTX, MARA, NEE, RIOT, AMAT, PLUG, MRK, MSTR.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BCRXBioCryst
              CYTKCytokinetics
              DHRDanaher
              EWEdwards Lifesciences
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis